Results shown below
One of the best things about my role is speaking to staff. Since becoming Interim Chair, Iâve tried to meet as many staff as possible. Not only is it a critical part of the role, but itâs also one of the parts of the job I enjoy most. And so, while talking to a member of staff from Birmingham and Solihull ICS, they took the opportunity to ask me ââWhat does Windrush mean for the NHS?
The Windrush Generation endured the worst of racism and anti-blackness. It wasnât just the âcolour barâ âthat they endured but the ongoing issues of the impact of empire and colonisation. And we need to recognise, too, that racism and injustice can still be experienced today.
As the Patient Safety Commissioner, my role is to champion the voice of patients and my goal is that every patient will feel that their voice and views matter â and that means all patients.
Health care is becoming more digitalised, and data-driven. Precision medicine, clinical decision support systems and predictive analytics are no longer the future, but our present. Covid 19 has also accelerated the adoption of new technologies and new ways of working.
Pharmacogenomics is the study of how genetic variation affects responses to drugs. This includes both the efficacy and safety of drugs.
With equal pay at its heart, how much has Agenda for Change helped with differences in pay across the NHSâs ethnically diverse workforce?
A new programme of work to understand the needs of sickle cell patients and identify improvements in managing acute painful sickle cell episodes is being undertaken by the NHS Race and Health Observatory
This report represents one of many steps needed to help understand the factors that shape race inequality in health, including the forces of structural racism and discrimination, and to begin to respond to them with impactful changes. Knowing how the system works, and how it interacts with underserved communities, is an important step towards rebuilding that system in a way that truly has equality at its core. We invite those reading this report to join us on that journey.
First Do No Harm, the independent review of the safety of medicines and medical devices led by Baroness Julia Cumberlege, found that patientsâ voices were ignored, and that the health system did not listen and act, but was defensive, dismissive, and disjointed. As the first ever Patient Safety Commissioner I have been listening to patients and patient safety experts to understand what needs to improve.
